• Protocols

• A081801

  OPEN TO ACCRUAL

  PhIII Study of Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC
  
  

• A151216

  OPEN TO ACCRUAL

  Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)